22/03/2024 - Press release
Having a higher biological or epigenetic age, which differs from chronological age and is influenced by lifestyle habits and external environmental factors, increases the risk of death in patients treated for a subarachnoid hemorrhage. Conversely, having a lower biological age increases the likelihood of experiencing one of the most common complications in these cases, the spasm of the cerebral arteries, known as vasospasm. This is the first time this relationship can be demonstrated, opening the door to research on how these factors can be modified to improve patient prognosis.
14/03/2024 - Press release
An international study published in Science Translational Medicine involving the Hospital del Mar Research Institute and the Vall d'Hebron Research Institute shows that there are substantial differences between men and women in the energy metabolism of renal tubular cells. In men with diabetes, more markers of oxidative stress in cells and processes linked to cell death are detected, which may predispose to diabetic nephropathy. The work may provide tools to personalize the treatment and evolution of people with diabetes and kidney disease, as well as to detect possible therapeutic targets based on this fact.
Més informació "Renal cell metabolism in diabetic men predisposes to renal disease"
13/03/2024 - Press release
The institution's Governing Council has approved the appointment of Dr. Raventós, who had already been manager of the institution between 2008 and 2011. He will take over the position from April 1 from Dr. Olga Pané, who has been manager for the last twelve years. The Governing Council of Consorci Mar Parc de Salut (Hospital del Mar) has approved the appointment of Dr. Jaume Raventós as the new manager of the institution. Dr. Raventós will replace Dr. Olga Pané as of April 1 due to her retirement. Dr. Pané has held the position of manager between 2011 and the present.
06/03/2024 - Press release
Between 1990 and 2019, the incidence of myocardial infarction in the Girona area decreased by 1% in women and 4% in men each year in the population aged 35 to 74 years, while, in the last 10 years, its lethality, the number of people who die 28 days after the onset of symptoms, has remained stagnant at around 15%. Data from almost five million hospital admissions and more than 70,000 death certificates have been analyzed as part of the REGICOR study, Registre Gironí del COR. These data suggest that primary prevention and rapidity of care have contributed to reducing the incidence of infarction and sudden death, increasing the chances of survival among patients arriving at the hospital.
Més informació "Decline in the mortality rate of people who suffer myocardial infarction stalls"
21/02/2024 - Press release
This is an international collaborative work coordinated by the Hospital del Mar Research Institut and the Hospital Clínic-IDIBAPS, published in the Journal of Neurology. This new tool may make it possible to adapt the monitoring and treatment of patients to their future evolution, opting for the most effective, but with more possible side effects in those with worse prognosis. The exact factors behind the progression of disability in multiple sclerosis, a disease with great heterogeneity, are unknown, which is why it is so important to have tools of this type.
15/02/2024 - Press release
A study by Hospital del Mar and Hospital General de Catalunya shows that this new type of device is three times more effective than previous models in completely closing the aneurysm. Moreover, in a safe way. It is published in the Journal of Neurointerventional Surgery. The new generation of stents for the treatment of cerebral aneurysms is more effective and safer, according to a study by Hospital del Mar and Hospital General de Catalunya that has just been published in the Journal of Neurointerventional Surgery. In fact, they are three times more effective, with practically no complications.
Més informació "Efficacy of the new generation of stents to treat cerebral aneurysm validated"
09/02/2024 - Press release
An international study has used a computational biology tool that, by analysing a multitude of biological data from multiple sclerosis patients ranging from genetic information to the whole organism, reveals the relationship between elements of different biological scales and improves our knowledge and the diagnosis of the disease. International research led by the Department of Medicine and Life Sciences (MELIS) at Pompeu Fabra University, in collaboration with Hospital del Mar, Hospital Clínic, Charité - Medical University of Berlin, and the universities of Oslo and Genoa, has developed a computational biology tool, based on multi-level network analysis, to achieve an integrated vision of multiple sclerosis. This tool could be used to study other complex diseases such as types of dementia.
30/01/2024 - Press release
This is revealed by the largest observational study in this field carried out to date in the world. It is published in the journal Nutrients. The work is based on data from the UK Biobank database and has made it possible to analyze information from more than 260,000 people. Its conclusions may allow a more detailed definition of future studies on omega-3 supplementation for the prevention of dementia. The potential benefits of these fatty acids are maximal in men over 60 and in dementias other than Alzheimer's disease.
10/01/2024 - Press release
Functional alterations in the brains of individuals with this condition coincide with the distribution of these neurons in the same brain. These neurons are responsible for filtering external information reaching the brain. Their functioning is altered in individuals with schizophrenia, which explains the majority of their symptoms. This discovery is the first time that this alteration can be identified as a possible origin of schizophrenic symptoms, and it opens the door to seeking new targeted treatments with fewer patient side effects.
28/12/2023 - Press release
An observational study conducted by researchers from Pompeu Fabra University and Hospital del Mar determines that the intradermal administration of the JYNNEOS vaccine against smallpox induces an efficient immune response that should protect people living with HIV from contracting the monkeypox virus.
Servei de Comunicació:
Marta Calsina Freixas(ELIMINAR)
Tel:
(+34) 93 316 06 80
Doctor Aiguader, 88
08226 Barcelona
© Institut Hospital del Mar
d'Investigacions MèdiquesLegal Notice and Privacy Policy | Cookie Policy | Site Index | Accessibility | Find Us | Contact
